Compare TNDM & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNDM | CRAI |
|---|---|---|
| Founded | 2006 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 924.0M |
| IPO Year | 2013 | 1998 |
| Metric | TNDM | CRAI |
|---|---|---|
| Price | $15.41 | $160.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 1 |
| Target Price | $28.00 | ★ $245.00 |
| AVG Volume (30 Days) | ★ 1.9M | 149.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | N/A | ★ 20.77 |
| EPS | N/A | ★ 8.14 |
| Revenue | ★ $1,014,736,000.00 | $751,583,000.00 |
| Revenue This Year | $8.11 | $7.82 |
| Revenue Next Year | $11.85 | $5.14 |
| P/E Ratio | ★ N/A | $19.21 |
| Revenue Growth | 7.93 | ★ 9.33 |
| 52 Week Low | $10.00 | $132.17 |
| 52 Week High | $29.65 | $227.29 |
| Indicator | TNDM | CRAI |
|---|---|---|
| Relative Strength Index (RSI) | 44.60 | 67.74 |
| Support Level | $13.59 | $152.81 |
| Resistance Level | $16.00 | $166.99 |
| Average True Range (ATR) | 0.81 | 6.07 |
| MACD | 0.02 | 1.89 |
| Stochastic Oscillator | 49.22 | 98.82 |
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.